SEC Form 4 · accession 0001019687-15-002116
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allen Wolff
Officer — CFO
Period of report
May 21, 2015
Accepted (ET)
May 21, 2015 · 8:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 21, 2015 | P | 65,500 | $0.36 | A | 65,500 | D |
Table II — derivative securities
No Table II lines on this filing.